172 related articles for article (PubMed ID: 10374683)
41. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
42. Prognostic factors for parotid metastasis of cutaneous squamous cell carcinoma of the head and neck.
Bobin C; Ingrand P; Dréno B; Rio E; Malard O; Espitalier F
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Apr; 135(2):99-103. PubMed ID: 29100720
[TBL] [Abstract][Full Text] [Related]
43. Prediction of Lymph Node Metastasis by Tumor Dimension Versus Tumor Biological Properties in Head and Neck Squamous Cell Carcinomas.
Jang JY; Kim MJ; Ryu G; Choi N; Ko YH; Jeong HS
Cancer Res Treat; 2016 Jan; 48(1):54-62. PubMed ID: 25761475
[TBL] [Abstract][Full Text] [Related]
44. Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).
Shikama N; Sasaki S; Nishikawa A; Koiwai K; Yoshino F; Hirase Y; Kawakami R; Kadoya M; Oguchi M
Radiology; 2003 Sep; 228(3):789-94. PubMed ID: 12954897
[TBL] [Abstract][Full Text] [Related]
45. [Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma].
Li XM; DI B; Shang YD; Li J; Cheng JM
Ai Zheng; 2005 Feb; 24(2):208-12. PubMed ID: 15694035
[TBL] [Abstract][Full Text] [Related]
46. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
[TBL] [Abstract][Full Text] [Related]
47. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
48. Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma.
Gross ND; Ellingson TW; Wax MK; Cohen JI; Andersen PE
Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):169-73. PubMed ID: 14967745
[TBL] [Abstract][Full Text] [Related]
49. Tumor angiogenesis as a predictor of tumor aggressiveness and metastatic potential in squamous cell carcinoma of the head and neck.
Carrau RL; Barnes EL; Snyderman CH; Petruzzelli G; Kachman K; Rueger R; D'Amico F; Johnson JT
Invasion Metastasis; 1995; 15(5-6):197-202. PubMed ID: 8765194
[TBL] [Abstract][Full Text] [Related]
50. [Diagnosis and management of squamous cell carcinoma of the head and neck region with unknown primary. A survey of 167 patients].
Issing WJ; Taleban B; Tauber S
Laryngorhinootologie; 2003 Sep; 82(9):659-65. PubMed ID: 14517763
[TBL] [Abstract][Full Text] [Related]
51. Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage.
Al-Othman MO; Mendenhall WM; Amdur RJ
Am J Otolaryngol; 2001; 22(6):387-90. PubMed ID: 11713722
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of level IV metastases from head and neck squamous cell carcinoma.
Hoch S; Katabi N; Daniel H; Franke N; Wiegand S; Zimmerman AP; Mandapathil M; Ferlito A; Teymoortash A
Head Neck; 2016 Jan; 38(1):140-6. PubMed ID: 25224439
[TBL] [Abstract][Full Text] [Related]
53. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
54. Preservation of the internal jugular vein in the radical treatment of node-positive neck--is it safe?
Martins EP; Filho JG; Agra IM; Carvalho AL; Magrin J; Kowalski LP
Ann Surg Oncol; 2008 Jan; 15(1):364-70. PubMed ID: 18026798
[TBL] [Abstract][Full Text] [Related]
55. Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma.
Temam S; Koka V; Mamelle G; Julieron M; Carmantrant R; Marandas P; Janot F; Bourhis J; Luboinski B
Head Neck; 2005 Aug; 27(8):653-8. PubMed ID: 16035097
[TBL] [Abstract][Full Text] [Related]
56. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
[TBL] [Abstract][Full Text] [Related]
57. A New Approach to Survival Analysis of Head and Neck Squamous Cell Carcinoma.
Masoudi S; Montazeri SA; Pourdanesh F; Biglarian A; Kazemi M; Rahgozar M
Arch Iran Med; 2017 Aug; 20(8):503-510. PubMed ID: 28846014
[TBL] [Abstract][Full Text] [Related]
58. Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma.
Papagerakis S; Bellile E; Peterson LA; Pliakas M; Balaskas K; Selman S; Hanauer D; Taylor JM; Duffy S; Wolf G
Cancer Prev Res (Phila); 2014 Dec; 7(12):1258-69. PubMed ID: 25468899
[TBL] [Abstract][Full Text] [Related]
59. TNM staging compared with a new clinicopathological model in predicting oral tongue squamous cell carcinoma survival.
Okuyemi OT; Piccirillo JF; Spitznagel E
Head Neck; 2014 Oct; 36(10):1481-9. PubMed ID: 23996811
[TBL] [Abstract][Full Text] [Related]
60. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
